ATLANTA, Oct. 7, 2011 /PRNewswire/ -- For the third quarter of 2011, Elekta continued its domination of the number one ranking in MD Buyline's user satisfaction surveys by earning the top overall composite rankings in all vital business areas: stereotactic radiosurgery (SRS), linear accelerators (tie with another provider), oncology information systems (OIS) and treatment planning systems (TPS). For six consecutive quarters, Elekta has placed first in 23 of 24 quarterly results, trending above the market average for the same time period.
Vendors are rated on a 1 to 10 scale according to user satisfaction with system performance, system reliability, system installation/implementation, applications training, service response time and service repair quality. MD Buyline clinical and IT analysts conduct interviews with hands-on users, including clinicians, physicians, biomedical engineers, physicists, nurses, CIOs and IT managers.
Important details of the Q3 survey include:
"We're gratified that our clinical users have once again rated our solutions and services as among the very best – it's a trend we intend to continue moving forward," says Jay Hoey, Executive Vice President Elekta North America.
MD Buyline measures user satisfaction based on evaluations by more than 3,300 hospitals in the member network. Founded in 1983, MD Buyline is a market intelligence organization that provides the healthcare industry with independent analysis and reporting.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.
Copyright©2010 PR Newswire.
All rights reserved